Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EXCLUSIVE: Eucomed comes out all guns blazing as MEPs admit changes needed to reg text

This article was originally published in Clinica

Executive Summary

The European medtech industry is hopeful that Article 22, the biggest bone of contention in the EU Medical Device Regulation text that relates to how high-risk devices will be regulated in the future, could be amended and further improved. This measure, as well as 27 other compromise amendments made to the text, have been voted through by the European Parliament's committee on the environment, public health and food safety (ENVI).






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts